Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35058173)
Watch
English
The chemotherapy of urologic cancer
scientific article published on August 1, 1975
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
title
The chemotherapy of urologic cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
oncology
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
author name string
S. K. Carter
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A125624
retrieved
6 December 2022
T. H. Wasserman
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A125624
retrieved
6 December 2022
language of work or name
English
0 references
publication date
1 August 1975
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
full work available at URL
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
volume
36
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
issue
2
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
page(s)
729-747
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
cites work
Intracavitary Chemotherapy of Diffuse Non-Infiltrating Papillary Carcinoma of the Bladder
series ordinal
1
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
The Use of Methotrexate in Advanced Carcinoma of the Bladder
series ordinal
4
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Five years clinical experience with 5-fluorouracil
series ordinal
6
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Cancer Research
series ordinal
10
volume
31
page(s)
1218
author name string
Barranco
publication date
1971
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Cancer chemotherapy by continuous intra-arterial infusion of methotrexate
series ordinal
16
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS
series ordinal
18
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
THE PATHOLOGY OF TESTICULAR TUMOURS. STUDIES FROM THE TESTICULAR TUMOUR PANEL AND REGISTRY OF THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND IN ASSOCIATION WITH THE BRITISH EMPIRE CANCER CAMPAIGN FOR RESEARCH
series ordinal
21
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Cancer of the urogenital tract: bladder cancer. The radiation attack.
series ordinal
25
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
A restudy of the first fourteen hundred tumors in the Bladder Tumor Registry, Armed Forces Institute of Pathology
series ordinal
26
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Mitomycin C in the treatment of metastatic transitional cell carcinoma of urinary bladder
series ordinal
27
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more.
series ordinal
32
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
THE EFFECT OF CYCLOPHOSPHAMIDE ON SOME URINARY TRACT TUMOURS
series ordinal
33
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Summary of results obtained with CB 1348
series ordinal
39
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth
series ordinal
44
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Carcinoma of the Bladder: Characteristic Modes of Local Invasion
series ordinal
46
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Infiltrating carcinoma of the bladder; relation of depth of penetration of the bladder wall to incidence of local extension and metastases
series ordinal
47
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Thiotepa in the treatment of tumours of the bladder
series ordinal
48
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Treatment of Advanced Prostatic Carcinoma with Estracyt: A Preliminary Report
series ordinal
49
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
The role of 5-fluorouracil in malignant disease
series ordinal
51
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Analysis in depth of bladder cancer treated by supervoltage therapy
series ordinal
52
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
A clinicopathologic analysis of adriamycin cardiotoxicity
series ordinal
54
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
HYDROXYUREA ADMINISTERED INTERMITTENTLY
series ordinal
56
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Effects of combined drug therapy on metastatic cancer of the testis
series ordinal
58
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Chemotherapy of metastatic testis cancer. Results in 154 patients
series ordinal
59
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Mithramycin in Metastatic Urogenital Cancer
series ordinal
60
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Mitomycin-C in the therapy of far-advanced malignant tumors
series ordinal
61
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Clinical trials with adriamycin
series ordinal
63
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
SUPERVOLTAGE IRRADIATION FOR CARCINOMA OF THE URINARY BLADDER
series ordinal
64
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Triple Chemotherapy in the Treatment of Metastatic Testicular Neoplasms
series ordinal
65
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Phase II evaluation of adriamycin in human neoplasia
series ordinal
70
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Chemotherapy of vesical and prostatic tumours
series ordinal
74
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Irradiation and 5-fluorouracil as Adjuvants in the Management of Invasive Bladder Carcinoma. A Cooperative Group Report after 4 Years
series ordinal
76
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Current Concepts in Genitourinary Oncology: A Multidisciplinary Approach
series ordinal
79
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Vinblastine in the management of testicular cancer
series ordinal
81
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia
series ordinal
82
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Surgical Management of Testis Tumors
series ordinal
91
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases
series ordinal
92
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Clinical evaluation of cancer chemotherapy with 5-fluorouracil
series ordinal
94
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study
series ordinal
95
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Bladder carcinoma treated by direct instillation of thio-TEPA
series ordinal
96
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors
series ordinal
97
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
An evaluation of 5-fluorouracil in malignant disease
series ordinal
98
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Chemotherapy of human solid tumors with 5-fluorouracil
series ordinal
105
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Proceedings: Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma
series ordinal
109
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
reference URL
https://api.crossref.org/works/10.1002/1097-0142(197508)36:2+%3C729::AID-CNCR2820360818%3E3.0.CO;2-D
retrieved
6 December 2022
Identifiers
DOI
10.1002/1097-0142(197508)36:2+<729::AID-CNCR2820360818>3.0.CO;2-D
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
PubMed ID
125624
1 reference
stated in
Europe PubMed Central
PubMed ID
125624
retrieved
6 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
